Cargando…
Prognostic Value of Triglyceride to High-Density Lipoprotein Cholesterol Ratio (TG/HDL-C) in IgA Nephropathy Patients
BACKGROUND: The triglycerides to high-density lipoprotein cholesterol (TG/HDL-C) ratio is an easy-to-use atherogenic and prognostic marker which has attracted increasing attention these days. However, whether TG/HDL-C correlate with outcomes in IgA nephropathy (IgAN) patients remains unknown. To cla...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9251124/ https://www.ncbi.nlm.nih.gov/pubmed/35795149 http://dx.doi.org/10.3389/fendo.2022.877794 |
_version_ | 1784739969701511168 |
---|---|
author | Pei, Gaiqin Qin, Aiya Dong, Lingqiu Wang, Siqing Liu, Xiang Yang, Dandan Tan, Jiaxing Zhou, Xiaoyuan Tang, Yi Qin, Wei |
author_facet | Pei, Gaiqin Qin, Aiya Dong, Lingqiu Wang, Siqing Liu, Xiang Yang, Dandan Tan, Jiaxing Zhou, Xiaoyuan Tang, Yi Qin, Wei |
author_sort | Pei, Gaiqin |
collection | PubMed |
description | BACKGROUND: The triglycerides to high-density lipoprotein cholesterol (TG/HDL-C) ratio is an easy-to-use atherogenic and prognostic marker which has attracted increasing attention these days. However, whether TG/HDL-C correlate with outcomes in IgA nephropathy (IgAN) patients remains unknown. To clarify these issues, we conducted this study. METHODS: A total of 1146 patients from West China Hospital of Sichuan University were retrospectively analysed between 2008 and 2018.The demographic, clinical and pathological data of all patients at the time of biopsy were collected. Then, patients were divided into the high TG/HDL group (TG/HDL ≥ 1.495, N=382) and the low TG/HDL group (TG/HDL-C < 1.495, N=764) based on the optimal cut-off value of the TG/HDL-C using receive operating curve. Cox proportional hazard models and Kaplan–Meier curves were used to evaluate the renal outcomes of IgAN. RESULTS: The median age of the patients was 33 (26-42) years, and 44.5% were men. By correlation analysis, we found that the TG/HDL-C ratio was negatively correlated with the eGFR (r = 0.250, P < 0.001) but positively correlated with proteinuria (r = 0.230, P< 0.001), BMI (r=0.380, P<0.001) and serum uric (r =0.308, P< 0.001). Patients with a higher TG/HDL-C ratio tended to have hypertension [odds ratio (OR), 1.987; 95% CI, 1.527-2.587; P<0.001] and more severe pathologic lesions with tubular atrophy/interstitial fibrosis (OR, 1.610; 95% CI, 1.203-2.154; P=0.001). During a median follow-up period of 54.1 (35.6-73.2) months, a high TG/HDL ratio was strongly associated with worse renal survival in IgAN patients (log-rank: P <0.001). Multivariate Cox analysis demonstrated that a high TG/HDL-C ratio (HR 1.775, 95% CI 1.056-2.798; P=0.029) was an independent predictive marker to ESRD. CONCLUSION: In this study, we addressed the importance of TG/HDL-C ratio as a predictive marker for IgAN progression. |
format | Online Article Text |
id | pubmed-9251124 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-92511242022-07-05 Prognostic Value of Triglyceride to High-Density Lipoprotein Cholesterol Ratio (TG/HDL-C) in IgA Nephropathy Patients Pei, Gaiqin Qin, Aiya Dong, Lingqiu Wang, Siqing Liu, Xiang Yang, Dandan Tan, Jiaxing Zhou, Xiaoyuan Tang, Yi Qin, Wei Front Endocrinol (Lausanne) Endocrinology BACKGROUND: The triglycerides to high-density lipoprotein cholesterol (TG/HDL-C) ratio is an easy-to-use atherogenic and prognostic marker which has attracted increasing attention these days. However, whether TG/HDL-C correlate with outcomes in IgA nephropathy (IgAN) patients remains unknown. To clarify these issues, we conducted this study. METHODS: A total of 1146 patients from West China Hospital of Sichuan University were retrospectively analysed between 2008 and 2018.The demographic, clinical and pathological data of all patients at the time of biopsy were collected. Then, patients were divided into the high TG/HDL group (TG/HDL ≥ 1.495, N=382) and the low TG/HDL group (TG/HDL-C < 1.495, N=764) based on the optimal cut-off value of the TG/HDL-C using receive operating curve. Cox proportional hazard models and Kaplan–Meier curves were used to evaluate the renal outcomes of IgAN. RESULTS: The median age of the patients was 33 (26-42) years, and 44.5% were men. By correlation analysis, we found that the TG/HDL-C ratio was negatively correlated with the eGFR (r = 0.250, P < 0.001) but positively correlated with proteinuria (r = 0.230, P< 0.001), BMI (r=0.380, P<0.001) and serum uric (r =0.308, P< 0.001). Patients with a higher TG/HDL-C ratio tended to have hypertension [odds ratio (OR), 1.987; 95% CI, 1.527-2.587; P<0.001] and more severe pathologic lesions with tubular atrophy/interstitial fibrosis (OR, 1.610; 95% CI, 1.203-2.154; P=0.001). During a median follow-up period of 54.1 (35.6-73.2) months, a high TG/HDL ratio was strongly associated with worse renal survival in IgAN patients (log-rank: P <0.001). Multivariate Cox analysis demonstrated that a high TG/HDL-C ratio (HR 1.775, 95% CI 1.056-2.798; P=0.029) was an independent predictive marker to ESRD. CONCLUSION: In this study, we addressed the importance of TG/HDL-C ratio as a predictive marker for IgAN progression. Frontiers Media S.A. 2022-06-20 /pmc/articles/PMC9251124/ /pubmed/35795149 http://dx.doi.org/10.3389/fendo.2022.877794 Text en Copyright © 2022 Pei, Qin, Dong, Wang, Liu, Yang, Tan, Zhou, Tang and Qin https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Endocrinology Pei, Gaiqin Qin, Aiya Dong, Lingqiu Wang, Siqing Liu, Xiang Yang, Dandan Tan, Jiaxing Zhou, Xiaoyuan Tang, Yi Qin, Wei Prognostic Value of Triglyceride to High-Density Lipoprotein Cholesterol Ratio (TG/HDL-C) in IgA Nephropathy Patients |
title | Prognostic Value of Triglyceride to High-Density Lipoprotein Cholesterol Ratio (TG/HDL-C) in IgA Nephropathy Patients |
title_full | Prognostic Value of Triglyceride to High-Density Lipoprotein Cholesterol Ratio (TG/HDL-C) in IgA Nephropathy Patients |
title_fullStr | Prognostic Value of Triglyceride to High-Density Lipoprotein Cholesterol Ratio (TG/HDL-C) in IgA Nephropathy Patients |
title_full_unstemmed | Prognostic Value of Triglyceride to High-Density Lipoprotein Cholesterol Ratio (TG/HDL-C) in IgA Nephropathy Patients |
title_short | Prognostic Value of Triglyceride to High-Density Lipoprotein Cholesterol Ratio (TG/HDL-C) in IgA Nephropathy Patients |
title_sort | prognostic value of triglyceride to high-density lipoprotein cholesterol ratio (tg/hdl-c) in iga nephropathy patients |
topic | Endocrinology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9251124/ https://www.ncbi.nlm.nih.gov/pubmed/35795149 http://dx.doi.org/10.3389/fendo.2022.877794 |
work_keys_str_mv | AT peigaiqin prognosticvalueoftriglyceridetohighdensitylipoproteincholesterolratiotghdlciniganephropathypatients AT qinaiya prognosticvalueoftriglyceridetohighdensitylipoproteincholesterolratiotghdlciniganephropathypatients AT donglingqiu prognosticvalueoftriglyceridetohighdensitylipoproteincholesterolratiotghdlciniganephropathypatients AT wangsiqing prognosticvalueoftriglyceridetohighdensitylipoproteincholesterolratiotghdlciniganephropathypatients AT liuxiang prognosticvalueoftriglyceridetohighdensitylipoproteincholesterolratiotghdlciniganephropathypatients AT yangdandan prognosticvalueoftriglyceridetohighdensitylipoproteincholesterolratiotghdlciniganephropathypatients AT tanjiaxing prognosticvalueoftriglyceridetohighdensitylipoproteincholesterolratiotghdlciniganephropathypatients AT zhouxiaoyuan prognosticvalueoftriglyceridetohighdensitylipoproteincholesterolratiotghdlciniganephropathypatients AT tangyi prognosticvalueoftriglyceridetohighdensitylipoproteincholesterolratiotghdlciniganephropathypatients AT qinwei prognosticvalueoftriglyceridetohighdensitylipoproteincholesterolratiotghdlciniganephropathypatients |